GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
NCDC commissions infectious disease treatment centre in Katsina
‘The treatment centre in Katsina is the fifth to be commissioned in less than one year, with 11 others at various stages of development’ The Nigeria Centre for Disease Control
Addressing stunting among children
A News Analysis By Ibukun Emiola News Agency of Nigeria (NAN) Most people are unmindful of the connections between nutrition and physical growth of their children, especially in Africa, heath
African Health Ministers adopt measures to attain universal health coverage commit
African health ministers meeting in Zimbabwe for the 67th Session of the World Health Organization (WHO) Regional Committee, which kicked off today, have adopted a range of actions intended to
0 Comments
No Comments Yet!
You can be first to comment this post!